138 related articles for article (PubMed ID: 19630816)
1. Altered megakaryocytopoiesis in von Willebrand type 2B disease.
Nurden AT; Federici AB; Nurden P
J Thromb Haemost; 2009 Jul; 7 Suppl 1():277-81. PubMed ID: 19630816
[TBL] [Abstract][Full Text] [Related]
2. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B.
Nurden P; Gobbi G; Nurden A; Enouf J; Youlyouz-Marfak I; Carubbi C; La Marca S; Punzo M; Baronciani L; De Marco L; Vitale M; Federici AB
Blood; 2010 Apr; 115(13):2649-56. PubMed ID: 20118404
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
4. Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia.
Nurden P; Debili N; Vainchenker W; Bobe R; Bredoux R; Corvazier E; Combrie R; Fressinaud E; Meyer D; Nurden AT; Enouf J
Blood; 2006 Oct; 108(8):2587-95. PubMed ID: 16720832
[TBL] [Abstract][Full Text] [Related]
5. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
6. Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.
Slayton WB; Patel M; Sola-Visner M; Harris N; Rivers A; Montgomery RR; Friedman KD
J Pediatr Hematol Oncol; 2008 Sep; 30(9):708-11. PubMed ID: 18776767
[TBL] [Abstract][Full Text] [Related]
7. The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse.
Kanaji S; Morodomi Y; Weiler H; Zarpellon A; Montgomery RR; Ruggeri ZM; Kanaji T
Haematologica; 2022 Sep; 107(9):2133-2143. PubMed ID: 35142156
[TBL] [Abstract][Full Text] [Related]
8. Terminal platelet production is regulated by von Willebrand factor.
Poirault-Chassac S; Nguyen KA; Pietrzyk A; Casari C; Veyradier A; Denis CV; Baruch D
PLoS One; 2013; 8(5):e63810. PubMed ID: 23737952
[TBL] [Abstract][Full Text] [Related]
9. Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions.
Golder M; Pruss CM; Hegadorn C; Mewburn J; Laverty K; Sponagle K; Lillicrap D
Blood; 2010 Jun; 115(23):4862-9. PubMed ID: 20371742
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
Ju L; Dong JF; Cruz MA; Zhu C
J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
[TBL] [Abstract][Full Text] [Related]
11. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
Martin C; Morales LD; Cruz MA
J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of type 2 von Willebrand disease.
Fressinaud E; Mazurier C; Meyer D
Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
[TBL] [Abstract][Full Text] [Related]
14. The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.
Zhang C; Kelkar A; Nasirikenari M; Lau JTY; Sveinsson M; Sharma UC; Pokharel S; Neelamegham S
J Thromb Haemost; 2018 Mar; 16(3):571-582. PubMed ID: 29251812
[TBL] [Abstract][Full Text] [Related]
15. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis.
Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A
Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311
[TBL] [Abstract][Full Text] [Related]
16. The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor.
Ribba AN; Hilbert L; Lavergne JM; Fressinaud E; Boyer-Neumann C; Ternisien C; Juhan-Vague I; Goudemand J; Girma J; Mazurier C; Meyer D
Blood; 2001 Feb; 97(4):952-9. PubMed ID: 11159522
[TBL] [Abstract][Full Text] [Related]
17. Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.
Castaman G; Federici AB
Semin Thromb Hemost; 2016 Jul; 42(5):478-82. PubMed ID: 27148840
[TBL] [Abstract][Full Text] [Related]
18. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
[TBL] [Abstract][Full Text] [Related]
19. A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B "Malmö/New York" von Willebrand disease.
Lavenu-Bombled C; Guitton C; Dupuis A; Baas MJ; Desconclois C; Dreyfus M; Li R; Caron C; Gachet C; Fressinaud E; Lanza F
Thromb Haemost; 2016 Nov; 116(6):1070-1078. PubMed ID: 27683759
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M
J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
